1/103
Comprehensive practice flashcards reviewing TNM breast staging guidelines, DCIS and Paget disease definitions, histologic subtyping, isolated tumor cells (ITCs), micrometastases, and phyllodes tumor classification and grading criteria.
What is pTis (DCIS)?
Ductal carcinoma in situ.
What is pTis (Paget)?
Paget disease of the nipple NOT associated with invasive carcinoma and/or DCIS in the underlying breast parenchyma.
How should a breast carcinoma associated with Paget disease be categorized when carcinoma is present in the breast parenchyma?
Categorize it based on the size and characteristics of the parenchymal disease; the presence of Paget disease should also be noted.
What is the topic of the slide titled “Sectioning”?
Size of tumor estimation and sectioning methods are illustrated, including DCIS in one block, serial sequential sampling, nonsequential sampling, and margins.
What does the slide identify as the purpose of estimating DCIS size?
The slide illustrates estimating the extent/size of DCIS using the specimen and sectioning approach; it does not provide a separate numeric pT size threshold.
When should a pN category be chosen according to the lecture?
Choose a category if lymph nodes are received with the specimen; immunohistochemistry and/or molecular studies are not required.
When is pN not assigned because no nodes were submitted or found?
When no nodes are submitted or found.
When is pN not assigned because of insufficient information?
When the category cannot be determined based on available pathological information.
How are isolated tumor cells (ITCs) defined in lymph node staging?
Small clusters of cells no larger than 0.2mm, or single tumor cells, or a cluster of fewer than 200 cells in a single histologic cross-section.
How may ITCs be detected?
By routine histology or by immunohistochemical (IHC) methods.
How are nodes containing only ITCs handled when determining the N category?
They are excluded from the total positive node count when determining the N category, but should be included in the total number of nodes evaluated.
What is pN0 in breast staging?
No regional lymph node metastasis identified or ITCs only.
What is pN0(i+)?
ITCs only: malignant cell clusters no larger than 0.2mm in regional lymph node(s).
What is pN0(mol+)?
Positive molecular findings by reverse transcriptase polymerase chain reaction (RT-PCR); no ITCs detected.
What is pN1mi?
Micrometastases: approximately 200 cells, larger than 0.2mm, but none larger than 2.0mm.
What is the lecture’s approximate cell-count explanation for a 0.2mm cluster?
Approximately 1,000 tumor cells are contained in a three-dimensional 0.2mm cluster.
How should more than 200 individual tumor cells in one histologic section be interpreted when distinguishing ITCs from micrometastasis?
If more than 200 individual tumor cells are identified as single dispersed cells or as a nearly confluent elliptical or spherical focus in a single histologic section of a lymph node, there is a high probability that more than 1,000 cells are present; classify the node as containing a micrometastasis (pN1mi).
Are cells in different lymph-node cross-sections added together to reach the 200-cell threshold?
No. Cells in different lymph-node cross-sections, longitudinal sections, or levels of the block are not added together; the 200 cells must be in a single node profile, even if the node has been thinly sectioned into multiple slices.
What caution does the lecture give about the 200-cell threshold for ITCs versus micrometastasis?
There is substantial overlap between the upper limit of ITCs and the lower limit of micrometastasis because of limitations in pathologic nodal evaluation and detection of minimal tumor burden. The 200-cell threshold in a single cross-section is a guideline; the pathologist should use judgment.
What is pN1a?
Metastases in 1–3 axillary lymph nodes, with at least one metastasis larger than 2.0mm.
What is pN1b?
Metastases in ipsilateral internal mammary sentinel nodes, excluding ITCs.
What is pN1c?
pN1a and pN1b combined.
What is pN2a?
Metastases in 4–9 axillary lymph nodes, with at least one tumor deposit larger than 2.0mm.
What is pN2b?
Metastases in clinically detected internal mammary lymph nodes, with or without microscopic confirmation, and with pathologically negative axillary nodes.
What is pN3a?
Metastases in 10 or more axillary lymph nodes, with at least one tumor deposit larger than 2.0mm; OR metastases to the infraclavicular (Level III axillary lymph) nodes.
What is pN3b?
pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); OR pN2a in the presence of pN1b.
What is pN3c?
Metastases in ipsilateral supraclavicular lymph nodes.
When is the breast CIS pM category required?
Only if confirmed pathologically.
What is the pM category when it cannot be determined from the submitted specimen(s)?
Not applicable — pM cannot be determined from the submitted specimen(s).
What is pM1 for breast CIS?
Histologically proven metastases larger than 0.2mm.
What additional information is recorded when metastasis is from a previous procedure?
Specify the case number(s) with metastasis from a previous procedure.
What does “pT not assigned” mean?
The category cannot be determined based on available pathological information.
What is pT0?
No evidence of primary tumor.
What is the pT1 size range for breast carcinoma?
Tumor 20mm or less in greatest dimension.
What is pT1mi?
Tumor 1mm or less in greatest dimension.
How does the lecture instruct rounding a measurement greater than 1.0–1.9mm?
Round any measurement greater than 1.0–1.9mm to 2mm.
What is pT1a?
Tumor greater than 1mm but 5mm or less in greatest dimension.
What is pT1b?
Tumor greater than 5mm but 10mm or less in greatest dimension.
What is pT1c?
Tumor greater than 10mm but 20mm or less in greatest dimension.
What is pT1 when the subcategory cannot be determined?
pT1 (subcategory cannot be determined).
What is pT2 in breast carcinoma staging?
Tumor greater than 20mm but 50mm or less in greatest dimension.
What is pT3 in breast carcinoma staging?
Tumor greater than 50mm in greatest dimension.
Does invasion of the dermis alone qualify as pT4?
No. Invasion of the dermis alone does not qualify as pT4.
What is the overall pT4 definition for breast carcinoma?
Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules).
What is pT4a?
Extension to the chest wall; invasion or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4.
What is pT4b?
Ulceration and/or ipsilateral satellite nodules and/or edema (including peau d’orange) of the skin that do not meet the criteria for inflammatory carcinoma.
What is pT4c?
Both T4a and T4b are present.
What clinical findings are required for inflammatory carcinoma?
Clinical findings of erythema and edema involving at least one-third or more of the skin of the breast.
What is pT4d?
Inflammatory carcinoma.
What does “pT4 with subcategory unable to be determined” mean?
pT4 (subcategory cannot be determined).
Which histologic types of invasive carcinoma are listed in the lecture?
Invasive carcinoma of no special type (ductal); Invasive carcinoma of no special type (ductal) with specific morphologic pattern; Invasive lobular carcinoma, classic; Invasive lobular carcinoma, variant pattern; Mixed histologic types; Tubular carcinoma, pure or > 90%; Invasive cribriform carcinoma, pure or > 90%; Mucinous carcinoma, pure or > 90%; Invasive micropapillary carcinoma, pure or > 90%; Invasive apocrine carcinoma; Metaplastic carcinoma variants; Invasive solid papillary carcinoma; Adenoid cystic carcinoma, classic; Secretory carcinoma.
What specimen is illustrated on slide 12?
A wire-localized lumpectomy specimen with suture markings prior to inking (photograph caption).
What is illustrated on slide 13?
A sectioned lumpectomy specimen shown with its corresponding radiographic image.
What specimen is illustrated on slide 14?
A mastectomy specimen with a radiographic biopsy marker.
What does slide 15 illustrate?
A gross example of invasive breast carcinoma.
What gross features are labeled on the invasive breast carcinoma image (slide 16)?
Non-neoplastic breast parenchyma is indicated by a blue arrow; infiltrative tumor with a firm, gray-white cut surface is indicated by a red arrow.
What specimen is illustrated on slide 17?
A mastectomy specimen photograph.
Does the measured size of invasive carcinoma include surrounding carcinoma in situ?
No. The size of invasive carcinoma does not include surrounding carcinoma in situ.
If multiple invasive carcinomas are present, which size is used for pT?
The size of the largest invasive carcinoma is used for pT.
What modifier is used to designate multiple invasive carcinomas?
Use modifier “m” to designate multiple.
How far apart should multiple invasive carcinomas be according to the lecture?
Multiple tumors should be 5mm or more apart.
What does slide 19 illustrate?
A gross photograph labeled “Multifocal breast cancer”; no additional written staging definition is provided on this slide.
What is the lecture’s note about the number of lymph nodes evaluated?
At least 10 nodes (up to 40 possible) — sentinel and non-sentinel.
How are micro- and macrometastases handled in the pN total?
The slide notes that micro- and macrometastases are added for the pN total.
How are sentinel lymph nodes described in the lecture?
Sentinel nodes are identified by dye; fewer than 6 are noted, with modifier “sn”.
How are axillary lymph nodes described regarding removal?
Axillary tissue is removed en bloc.
What other lymph-node types are listed in slide 21?
Intramammary nodes; internal mammary, supraclavicular, and infraclavicular nodes.
What should be done with grossly positive lymph nodes?
Grossly positive nodes should be identified.
When is the breast pM category required in staging?
Only if confirmed pathologically.
What is pM1 for invasive breast carcinoma?
Distant metastasis.
What features are required for a diagnosis of malignant phyllodes tumor according to slide 23?
At least half of three adverse features: marked stromal cellularity, marked stromal atypia, stromal overgrowth, an infiltrative tumor border, and greater than or equal to 10 mitoses per 10 high-power fields (HPFs).
What is the lecture’s borderline classification note for phyllodes tumors?
Tumors with up to three of these adverse features should be classified as borderline when some but not all of the other histologic features of malignancy are observed. See Note A for additional details.
Which phyllodes tumor categories are listed?
Phyllodes tumor, benign; phyllodes tumor, borderline; phyllodes tumor, malignant. A histologic type comment line is also provided.
How is stromal cellularity graded in benign, borderline, and malignant phyllodes tumors?
Benign: mild. Borderline: moderate. Malignant: marked.
How is stromal atypia graded in benign, borderline, and malignant phyllodes tumors?
Benign: mild or none. Borderline: mild or moderate. Malignant: marked.
How is stromal overgrowth described across phyllodes categories?
Benign: absent. Borderline: absent or very focal. Malignant: present.
What mitotic rate is listed for benign phyllodes tumor?
Less than 5 mitoses per 10HPFs or less than 2.5mitoses per mm2.
What mitotic rate is listed for borderline phyllodes tumor?
5–9 mitoses per 10HPFs or 2.5 to less than 5mitoses per mm2.
What mitotic rate is listed for malignant phyllodes tumor?
10 or more mitoses per 10HPFs or 5 or more mitoses per mm2.
How is the tumor border described in benign phyllodes tumor?
Circumscribed.
How is the tumor border described in borderline phyllodes tumor?
Usually circumscribed but may be focally infiltrative.
How is the tumor border described in malignant phyllodes tumor?
Focally or extensively infiltrative (permeative).
Are malignant heterologous stromal elements present in benign or borderline phyllodes tumors?
Absent in both benign and borderline tumors.
Can malignant heterologous stromal elements be present in malignant phyllodes tumor?
Yes. They are sometimes present.
What does HPF mean in the phyllodes grading table?
High power field (40× objective and 10× eyepiece).
Which malignant heterologous elements are listed for malignant phyllodes tumor?
Osteosarcoma, chondrosarcoma, and rhabdomyosarcoma.
Does well-differentiated liposarcoma categorize a phyllodes tumor as malignant?
No. Well-differentiated liposarcoma is NOT used to categorize as malignant.
What is pT not assigned for phyllodes tumor?
The category cannot be determined based on available pathological information.
What is pT0 for phyllodes tumor?
No evidence of primary tumor.
What is phyllodes pT1?
Tumor 5cm or less in greatest dimension.
What is phyllodes pT2?
Tumor greater than 5cm but no more than 10cm.
What is phyllodes pT3?
Tumor greater than 10cm but no more than 15cm.
What is phyllodes pT4?
Tumor greater than 15cm in greatest dimension.
When is the phyllodes pN category not assigned because no lymph nodes are present?
When no lymph nodes are present, the pathologic N category is not assigned (pNX is not used and should not be reported).
What is phyllodes pN not assigned when no nodes are submitted or found?
pN not assigned (no nodes submitted or found).
What is phyllodes pN not assigned when information is insufficient?
pN not assigned (cannot be determined based on available pathological information).
What is phyllodes pN0?
No regional lymph node metastasis.
What is phyllodes pN1?
Regional lymph node metastasis.
When is the phyllodes pM category required?
Only if confirmed pathologically.
What is phyllodes pM when it cannot be determined from submitted specimen(s)?
Not applicable — pM cannot be determined from the submitted specimen(s).